ADME/TK Evaluation (S0663) of Dicyclohexylcarbodiimide (538-75-0) in F344 Rats and B6C3F1 Mice Exposed via Intravenous Injection or Dermal Application
Radiolabel Description:
Carbon-14 uniformly on the ring; Dicyclohexylcarbodiimide, [ring-UL-14C]-
Vehicles:
Intravenous, propylene glycol (containing up to 2% ethanol (v:v)); Dermal, hexanes.
Summary Data - Male Rats
- Dermal Single Dose (0.3 mg/kg, Study Duration 72 hours) (81KB)
- Dermal Single Dose (3.1 mg/kg, Study Duration 72 hours) (70KB)
- IV Single Dose (0.3 mg/kg, Study Duration 48 hours) (60KB)
- IV Single Dose (0.3 mg/kg, Study Duration 72 hours) (60KB)
- IV Single Dose (3 mg/kg, Study Duration 72 hours) (57KB)